2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-
| Title | Journal |
|---|---|
| Downregulation of NF-κB and PCNA in the regulatory pathways of apoptosis by cyclooxygenase-2 inhibitors in experimental lung cancer. | Molecular and cellular biochemistry 20121001 |
| Angiostatic role of the selective cyclooxygenase-2 inhibitor etoricoxib (MK0663) in experimental lung cancer. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20120901 |
| Safety of nonsteroidal antiinflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review. | The Journal of rheumatology. Supplement 20120901 |
| Pain pharmacotherapy in patients with inflammatory arthritis and concurrent cardiovascular or renal disease: a Cochrane systematic review. | The Journal of rheumatology. Supplement 20120901 |
| Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib. | European heart journal 20120801 |
| Acupuncture as an adjunctive therapy to pharmacological treatment in patients with chronic pain due to osteoarthritis of the knee: a 3-armed, randomized, placebo-controlled trial. | Pain 20120801 |
| Perioperative use of etoricoxib reduces pain and opioid side-effects after total abdominal hysterectomy: a double-blind, randomized, placebo-controlled phase III study. | Current medical research and opinion 20120801 |
| Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain relief. | European journal of pain (London, England) 20120701 |
| Chemopreventive effects of NSAIDs as inhibitors of cyclooxygenase-2 and inducers of apoptosis in experimental lung carcinogenesis. | Molecular and cellular biochemistry 20120701 |
| Pharmacokinetics and cardiovascular effect of etoricoxib in the absence or presence of St. John's Wort in rats. | Arzneimittel-Forschung 20120701 |
| Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial. | Medical oncology (Northwood, London, England) 20120601 |
| A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. | Rheumatology international 20120601 |
| [Effective pain management after hallux valgus correction]. | Pflege Zeitschrift 20120601 |
| Prescription of and adherence to non-steroidal anti-inflammatory drugs and gastroprotective agents in at-risk gastrointestinal patients. | The American journal of gastroenterology 20120501 |
| Single dose oral etoricoxib for acute postoperative pain in adults. | The Cochrane database of systematic reviews 20120418 |
| Prophylactic etoricoxib is effective in preventing 'first of Ramadan' headache: a placebo-controlled double-blind and randomized trial of prophylactic etoricoxib for ritual fasting headache. | Headache 20120401 |
| Glycosylation of human cyclooxygenase-2 (COX-2) decreases the efficacy of certain COX-2 inhibitors. | Pharmacological research 20120401 |
| Cyclooxygenase-1-selective inhibitors based on the (E)-2'-des-methyl-sulindac sulfide scaffold. | Journal of medicinal chemistry 20120308 |
| Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management. | Archives of dermatology 20120301 |
| Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease. | The Cochrane database of systematic reviews 20120215 |
| Detection of a minor amorphous phase in crystalline etoricoxib by dynamic mechanical analysis: comparison with Raman spectroscopy and modulated differential scanning calorimetry. | Journal of pharmaceutical sciences 20120201 |
| Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib. | Contact dermatitis 20120201 |
| Determination of free and total warfarin concentrations in plasma using UPLC MS/MS and its application to a patient samples. | Biomedical chromatography : BMC 20120101 |
| Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer's disease in rats. | Journal of molecular neuroscience : MN 20120101 |
| Sensitivity of single-domain versus multiple-domain outcome measures to identify responders in chronic low-back pain: pooled analysis of 2 placebo-controlled trials of etoricoxib. | The Clinical journal of pain 20120101 |
| Analgesic effect of etoricoxib (Arcoxia®) 120 mg during retinal laser photocoagulation. | European journal of ophthalmology 20120101 |
| Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cells. | Pharmacological research 20120101 |
| Differential role of cyclooxygenase isozymes on neuronal density in hippocampus CA1 region of intracerebroventricular streptozotocin treated rat brain. | Journal of chemical neuroanatomy 20120101 |
| Short stay and less pain after ambulatory anterior cruciate ligament (ACL) repair: COX-2 inhibitor versus glucocorticoid versus both combined. | Acta anaesthesiologica Scandinavica 20120101 |
| A comparison of the therapeutic efficacy of diclofenac in osteoarthritis: a systematic review of randomised controlled trials. | Current medical research and opinion 20120101 |
| Effects of combination therapy with celecoxib and doxycycline on neointimal hyperplasia and inflammatory biomarkers in coronary artery disease patients treated with bare metal stents. | Yonsei medical journal 20120101 |
| Factors implicated in radiation therapy failure and radiosensitization of prostate cancer. | Prostate cancer 20120101 |
| Do nonsteroidal anti-inflammatory drugs affect bone healing? A critical analysis. | TheScientificWorldJournal 20120101 |
| Reactive arthritis after the intravesical instillation of BCG. | Reumatologia clinica 20120101 |
| Adoption of new drugs by physicians: a survival analysis. | BMC health services research 20120101 |
| Case report: safety and efficacy of tocilizumab in a patient with rheumatoid arthritis and chronic hepatitis C. | Case reports in medicine 20120101 |
| Efficacy of etoricoxib, celecoxib, lumiracoxib, non-selective NSAIDs, and acetaminophen in osteoarthritis: a mixed treatment comparison. | The open rheumatology journal 20120101 |
| Nuclear factor kappa B: a pro-inflammatory, transcription factor-mediated signalling pathway in lung carcinogenesis and its inhibition by nonsteroidal anti-inflammatory drugs. | Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 20120101 |
| Gingival squamous cell carcinoma: A diagnostic impediment. | Journal of Indian Society of Periodontology 20120101 |
| Expressions of MMPs and TIMP-1 in gastric ulcers may differentiate H. pylori-infected from NSAID-related ulcers. | TheScientificWorldJournal 20120101 |
| Inhibition of ion channels and heart beat in Drosophila by selective COX-2 inhibitor SC-791. | PloS one 20120101 |
| Upregulation of intrinsic apoptotic pathway in NSAIDs mediated chemoprevention of experimental lung carcinogenesis. | Pharmacological reports : PR 20120101 |
| Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). | The Cochrane database of systematic reviews 20111109 |
| Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs. | Allergy 20111101 |
| Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity. | The Cochrane database of systematic reviews 20111005 |
| Patch testing in fixed drug eruptions--a 20-year review. | Contact dermatitis 20111001 |
| CONSORT recommendations in abstracts of randomised, controlled trials on migraine and headache. | The journal of headache and pain 20111001 |
| Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trials. | Alimentary pharmacology & therapeutics 20111001 |
| Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis. | Current medical research and opinion 20111001 |
| Protective effect of Etoricoxib against middle cerebral artery occlusion induced transient focal cerebral ischemia in rats. | European journal of pharmacology 20110930 |
| The use of etoricoxib and celecoxib for pain prevention after periodontal surgery: a double-masked, parallel-group, placebo-controlled, randomized clinical trial. | Journal of periodontology 20110901 |
| Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies. | Arthritis care & research 20110901 |
| Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. | PLoS medicine 20110901 |
| Antiarthritic activity of majoon suranjan (a polyherbal Unani formulation) in rat. | The Indian journal of medical research 20110901 |
| 6-Methyl-nicotinic acid. | Acta crystallographica. Section E, Structure reports online 20110901 |
| Defects in mouse nephrogenesis induced by selective and non-selective cyclooxygenase-2 inhibitors. | British journal of pharmacology 20110701 |
| A group IIA-secreted phospholipase A2 from snake venom induces lipid body formation in macrophages: the roles of intracellular phospholipases A2 and distinct signaling pathways. | Journal of leukocyte biology 20110701 |
| Individualized cost-effectiveness analysis. | PLoS medicine 20110701 |
| Etoricoxib-induced fixed drug eruption with positive lesional patch tests. | Cutaneous and ocular toxicology 20110601 |
| Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial. | Annals of the rheumatic diseases 20110601 |
| Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs. | The Journal of rheumatology 20110601 |
| 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. | Annals of the rheumatic diseases 20110601 |
| The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. | Annals of the rheumatic diseases 20110501 |
| Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction. | Pain 20110501 |
| Cyclooxygenase-2 contributes to functional changes seen on experimental hemorrhagic cystitis induced by ifosfamide in rat urinary bladder. | Cancer chemotherapy and pharmacology 20110401 |
| Inhibitory effect of selective cyclooxygenase-2 inhibitor etoricoxib on human organic anion transporter 3 (hOAT3). | Drug metabolism letters 20110401 |
| Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease. | Canadian journal of physiology and pharmacology 20110401 |
| Mechanistically probing lipid-siRNA nanoparticle-associated toxicities identifies Jak inhibitors effective in mitigating multifaceted toxic responses. | Molecular therapy : the journal of the American Society of Gene Therapy 20110301 |
| Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo. | Pain medicine (Malden, Mass.) 20110301 |
| Corticosteroids or cyclooxygenase 2-selective inhibitor medication for the management of pain and swelling after third-molar surgery. | The Journal of craniofacial surgery 20110301 |
| ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. | Annals of the rheumatic diseases 20110201 |
| Fixed drug eruption caused by etoricoxib--2 cases confirmed by patch testing. | Contact dermatitis 20110201 |
| The headache of the day of awe--no more? | Headache 20110201 |
| Development of multiple myeloma in a case of longstanding ankylosing spondylitis: more than a coincidence? | International journal of rheumatic diseases 20110201 |
| Effects of preemptive analgesia in laparoscopic cholecystectomy: a double-blind randomized controlled trial. | Surgical endoscopy 20110101 |
| A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain. | European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 20110101 |
| Evaluation of the dose range of etoricoxib in an acute pain setting using the postoperative dental pain model. | The Clinical journal of pain 20110101 |
| Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. | BMJ (Clinical research ed.) 20110101 |
| NSAID use selectively increases the risk of non-fatal myocardial infarction: a systematic review of randomised trials and observational studies. | PloS one 20110101 |
| Common secondary causes of resistant hypertension and rational for treatment. | International journal of hypertension 20110101 |
| Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study. | Arthritis research & therapy 20110101 |
| Heme oxygenase/carbon monoxide-biliverdin pathway may be involved in the antinociceptive activity of etoricoxib, a selective COX-2 inhibitor. | Pharmacological reports : PR 20110101 |
| Osteoarthritis subpopulations and implications for clinical trial design. | Arthritis research & therapy 20110101 |
| Development and pharmacological evaluation of cyclodextrin complexes of etoricoxib. | Acta poloniae pharmaceutica 20110101 |
| Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis. | BMC medicine 20110101 |
| Etoricoxibium picrate. | Acta crystallographica. Section E, Structure reports online 20110101 |
| Codeine did not increase analgesic efficacy of coxibs in contrast to that of paracetamol or ibuprofen: isobolographic analysis in mice. | Neuro endocrinology letters 20110101 |
| Prostacyclin: an inflammatory paradox. | Frontiers in pharmacology 20110101 |
| Adverse drug reactions of nonsteroidal anti-inflammatory drugs in orthopedic patients. | Journal of pharmacology & pharmacotherapeutics 20110101 |
| Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. | BMC complementary and alternative medicine 20110101 |
| Definition of nonresponse to analgesic treatment of arthritic pain: an analytical literature review of the smallest detectable difference, the minimal detectable change, and the minimal clinically important difference on the pain visual analog scale. | International journal of inflammation 20110101 |
| Longitudinal numbers-needed-to-treat (NNT) for achieving various levels of analgesic response and improvement with etoricoxib, naproxen, and placebo in ankylosing spondylitis. | BMC musculoskeletal disorders 20110101 |
| Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway. | International journal of rheumatology 20110101 |
| Synthesis of Diarylpyrazoles Containing a Phenylsulphone or Carbonitrile Moiety and their Chalcones as Possible Anti-Inflammatory Agents. | Scientia pharmaceutica 20110101 |
| Taste masked microspheres of ofloxacin: formulation and evaluation of orodispersible tablets. | Scientia pharmaceutica 20110101 |
| Preparation and Characterization of Metformin Hydrochloride - Compritol 888 ATO Solid Dispersion. | Journal of young pharmacists : JYP 20110101 |
| Single dose oral analgesics for acute postoperative pain in adults. | The Cochrane database of systematic reviews 20110101 |
| Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data. | BMC blood disorders 20110101 |
| Dissolution behavior of β-cyclodextrin molecular inclusion complexes of aceclofenac. | Journal of pharmacy & bioallied sciences 20110101 |
| Skeletal muscle protein metabolism in the elderly: Interventions to counteract the 'anabolic resistance' of ageing. | Nutrition & metabolism 20110101 |
| NSAID-sensitive antihistamine-induced urticaria/angioedema. | Journal of investigational allergology & clinical immunology 20110101 |
| Non-steroidal anti-inflammatory drug (NSAID) related inhibition of aldosterone glucuronidation and arterial dysfunction in patients with rheumatoid arthritis: a cross-sectional clinical study. | BMJ open 20110101 |
| Correlation versus causation? Pharmacovigilance of the analgesic flupirtine exemplifies the need for refined spontaneous ADR reporting. | PloS one 20110101 |
| Inhibition of HERG potassium channels by celecoxib and its mechanism. | PloS one 20110101 |
| Altered membrane lipid dynamics and chemoprevention by non-steroidal anti inflammatory drugs during colon carcinogenesis. | Nutricion hospitalaria 20110101 |
| Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini Review. | ISRN pharmacology 20110101 |
| Hepatic mitochondrial dysfunction in Friedreich ataxia. | BMC neurology 20110101 |
| Paracetamol and the placebo effect in osteoarthritis trials: a missing link? | Pain research and treatment 20110101 |
| Simultaneous estimation of etoricoxib and thiocolchicoside by RP-HPLC method in combined dosage forms. | Acta poloniae pharmaceutica 20110101 |
| Comparison of published orthopaedic trauma trials following registration in Clinicaltrials.gov. | BMC musculoskeletal disorders 20110101 |
| Pharmacokinetic and bioequivalence study of etoricoxib tablet in healthy Bangladeshi volunteers. | Arzneimittel-Forschung 20110101 |
| Systematic review of herbals as potential anti-inflammatory agents: Recent advances, current clinical status and future perspectives. | Pharmacognosy reviews 20110101 |
| Solubility and dissolution enhancement of etoricoxib by solid dispersion technique using sugar carriers. | ISRN pharmaceutics 20110101 |
| Formulation and evaluation of olanzapine matrix pellets for controlled release. | Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101 |
| Modular therapy approach in metastatic castration-refractory prostate cancer. | World journal of urology 20101201 |
| Are COX-2 inhibitors preferable to combined NSAID and PPI in countries with moderate health service expenditures? | Journal of evaluation in clinical practice 20101201 |
| Numbers-needed-to-treat analyses--do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials. | Pain 20101201 |
| Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. | Toxicological sciences : an official journal of the Society of Toxicology 20101201 |
| Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1. | Bioorganic & medicinal chemistry letters 20101201 |
| Long-term tolerability of etoricoxib in different types of NSAID-intolerant subjects. | European annals of allergy and clinical immunology 20101201 |
| Etoricoxib-induced life-threatening hyperkalemia and acute kidney dysfunction against the background of telmisartan and a low sodium diet. | International journal of emergency medicine 20101201 |
| Coxibs: a significant therapeutic opportunity. | Acta bio-medica : Atenei Parmensis 20101201 |
| Enthalpy relaxation studies of two structurally related amorphous drugs and their binary dispersions. | Drug development and industrial pharmacy 20101101 |
| Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients. | Alimentary pharmacology & therapeutics 20101101 |
| Compression of the superficial branch of the radial nerve by calcinosis cutis causing neuropathic pain. | The Journal of hand surgery, European volume 20101101 |
| Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury. | International journal of clinical practice 20101001 |
| Etoricoxib-induced toxic epidermal necrolysis: successful treatment with infliximab. | The Journal of dermatology 20101001 |
| Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells. | British journal of cancer 20100928 |
| Prophylactic etoricoxib is effective in preventing Yom Kippur headache: a placebo-controlled double-blind and randomized trial of prophylaxis for ritual fasting headache. | Headache 20100901 |
| The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment. | Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20100901 |
| Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay. | Phytotherapy research : PTR 20100901 |
| Leprosy: a precipitating factor for complex regional pain syndrome. | Minerva anestesiologica 20100901 |
| Structural and binding studies of C-terminal half (C-lobe) of lactoferrin protein with COX-2-specific non-steroidal anti-inflammatory drugs (NSAIDs). | Archives of biochemistry and biophysics 20100815 |
| Preemptive dexamethasone and etoricoxib for pain and discomfort prevention after periodontal surgery: a double-masked, crossover, controlled clinical trial. | Journal of periodontology 20100801 |
| Do the blood pressure effects of nonsteroidal antiinflammatory drugs influence cardiovascular morbidity and mortality? | Current hypertension reports 20100801 |
| Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol. | Anesthesia and analgesia 20100801 |
| Approval of etoricoxib is unacceptable! Authorised and reimbursed in France, despite an unfavourable risk-benefit balance. | Prescrire international 20100801 |
| Chemopreventive role of etoricoxib (MK-0663) in experimental colon cancer: induction of mitochondrial proapoptotic factors. | European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 20100701 |
| Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan. | Clinical therapeutics 20100701 |
| Exploiting cyclooxygenase-(in)dependent properties of COX-2 inhibitors for malignant glioma therapy. | Anti-cancer agents in medicinal chemistry 20100701 |
| Acute gouty arthritis in a patient after total knee arthroplasty. | Wiener klinische Wochenschrift 20100601 |
| Correlation of seizures and biochemical parameters of oxidative stress in experimentally induced inflammatory rat models. | Fundamental & clinical pharmacology 20100601 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20100601 |
| Phosphorodiamidate-directed metalation of N-heterocycles using Mg- and Zn-TMP bases. | Organic letters 20100507 |
| Pain control in first-trimester surgical abortion: a systematic review of randomized controlled trials. | Contraception 20100501 |
| Patient benefit-risk in arthritis--a rheumatologist's perspective. | Rheumatology (Oxford, England) 20100501 |
| A review of the gastrointestinal safety data--a gastroenterologist's perspective. | Rheumatology (Oxford, England) 20100501 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20100501 |
| Etoricoxib improves pain, function and quality of life: results of a real-world effectiveness trial. | International journal of rheumatic diseases 20100501 |
| Influence of etoricoxib on anticonvulsant activity of phenytoin and diazepam in experimental seizure models in mice. | The Journal of pharmacy and pharmacology 20100501 |
| Observation of oscillatory behavior during the dissolution of a pharmaceutical compound and evidence for the existence of an inverse Ostwald rule. | Physical chemistry chemical physics : PCCP 20100421 |
| Formulation and evaluation of mouth dissolving tablets of the Etoricoxib. | Pakistan journal of pharmaceutical sciences 20100401 |
| Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor. | British journal of cancer 20100216 |
| The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. | Blood 20100204 |
| Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. | Annals of the rheumatic diseases 20100201 |
| Absorption and distribution of etoricoxib in plasma, CSF, and wound tissue in patients following hip surgery--a pilot study. | Naunyn-Schmiedeberg's archives of pharmacology 20100201 |
| Taste masking of Etoricoxib by using ion-exchange resin. | Pharmaceutical development and technology 20100101 |
| Water displacement leg volumetry in clinical studies--a discussion of error sources. | BMC medical research methodology 20100101 |
| Bullous fixed drug eruption to etoricoxib--further evidence of intraepidermal CD8+ T cell involvement. | European journal of dermatology : EJD 20100101 |
| Management of hyperuricemia in gout: focus on febuxostat. | Clinical interventions in aging 20100101 |
| Nonsteroidal Anti-Inflammatory Drugs: A survey of practices and concerns of pediatric medical and surgical specialists and a summary of available safety data. | Pediatric rheumatology online journal 20100101 |
| Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor on aberrant crypt formation and apoptosis in 1,2 dimethyl hydrazine induced colon carcinogenesis in rat model. | Nutricion hospitalaria 20100101 |
| Cost effectiveness of etoricoxib versus celecoxib and non-selective NSAIDS in the treatment of ankylosing spondylitis. | PharmacoEconomics 20100101 |
| Leg ulceration in rheumatoid arthritis--an underreported multicausal complication with considerable morbidity: analysis of thirty-six patients and review of the literature. | Dermatology (Basel, Switzerland) 20100101 |
| The effect of prednisolone on reduction of complaints after impacted third molar removal. | Stomatologija 20100101 |
| [The assessment of oral NSAID use in patients with rheumatoid arthritis in Hungary--a cross sectional non interventional study]. | Acta pharmaceutica Hungarica 20100101 |
| Etoricoxib--preemptive and postoperative analgesia (EPPA) in patients with laparotomy or thoracotomy--design and protocols. | Trials 20100101 |
| Role and rationale for the use of milnacipran in the management of fibromyalgia. | Neuropsychiatric disease and treatment 20100101 |
| Design of group IIA secreted/synovial phospholipase A(2) inhibitors: an oxadiazolone derivative suppresses chondrocyte prostaglandin E(2) secretion. | PloS one 20100101 |
| Preparation and evaluation of transdermal plasters containing norfloxacin: a novel treatment for burn wound healing. | Eplasty 20100101 |
| Pregabalin in fibromyalgia--responder analysis from individual patient data. | BMC musculoskeletal disorders 20100101 |
| RNAi-based strategies for cyclooxygenase-2 inhibition in cancer. | Journal of biomedicine & biotechnology 20100101 |
| High-performance thin-layer chromatographic determination of etoricoxib and thiocolchicoside in combined tablet dosage form. | Journal of AOAC International 20100101 |
| Comparison of a minimally invasive posterior approach and the standard posterior approach for total hip arthroplasty A prospective and comparative study. | Journal of orthopaedic surgery and research 20100101 |
| Evaluation of chemopreventive response of two cycloxygenase-2 inhibitors, etoricoxib and diclofenac in rat colon cancer using FTIR and NMR spectroscopic techniques. | Nutricion hospitalaria 20100101 |
| [Comparative evaluation of the safety and efficacy of etoricoxib and diclofenac on the upper gastrointestinal tract in patients with osteoarthrosis and rheumatoid arthritis (the multinational etoricoxib and diclofenac arthritis long-term (MEDAL) study program)]. | Terapevticheskii arkhiv 20100101 |
| Inhibitory effect of selective cyclooxygenase-2 inhibitor lumiracoxib on human organic anion transporters hOAT1 and hOAT3. | Drug metabolism and pharmacokinetics 20100101 |
| Comparing etoricoxib and celecoxib for preemptive analgesia for acute postoperative pain in patients undergoing arthroscopic anterior cruciate ligament reconstruction: a randomized controlled trial. | BMC musculoskeletal disorders 20100101 |
| Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study. | International journal of medical sciences 20100101 |
| Masking the unpleasant taste of etoricoxib by crosslinked acrylic polymer based ion-exchange resin complexation. | Polimery w medycynie 20100101 |
| Musculoskeletal pain: prescription of NSAID and weak opioid by primary health care physicians in Sweden 2004-2008 - a retrospective patient record review. | Journal of pain research 20100101 |
| Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch. | Journal of pain research 20100101 |
| Anti-proliferative and apoptotic effects of etoricoxib, a selective COX-2 inhibitor, on 1,2-dimethylhydrazine dihydrochloride-induced colon carcinogenesis. | Asian Pacific journal of cancer prevention : APJCP 20100101 |
| Formulation and evaluation of extended-release solid dispersion of metformin hydrochloride. | Journal of young pharmacists : JYP 20100101 |
| Treatment with paracetamol, ketorolac or etoricoxib did not hinder alveolar bone healing: a histometric study in rats. | Journal of applied oral science : revista FOB 20100101 |
| Is it antiphospholipid syndrome? | International journal of rheumatology 20100101 |
| Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes. | Frontiers in pharmacology 20100101 |
| Effectiveness of diclofenac, ketorolac and etoricoxib in the treatment of acute pain from ankle fracture. | Proceedings of the Western Pharmacology Society 20100101 |
| Clinical efficacy of Rasona Pinda in the management of Amavata (rheumatoid arthritis). | Ayu 20100101 |
| Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis. | Journal of hypertension 20091201 |
| A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example. | PLoS medicine 20091201 |
| Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20091201 |
| COX-2 inhibitors in patients with sensitivity to nonselective NSAIDs. | The New England journal of medicine 20091126 |
| Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines. | Alimentary pharmacology & therapeutics 20091001 |
| Examination of the effect of increasing doses of etoricoxib on oral methotrexate pharmacokinetics in patients with rheumatoid arthritis. | Journal of clinical pharmacology 20091001 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20091001 |
| MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib. | Annals of the rheumatic diseases 20090901 |
| Women's health and gender-based clinical trials on etoricoxib: methodological gender bias. | Journal of public health (Oxford, England) 20090901 |
| Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo. | Rheumatology (Oxford, England) 20090901 |
| Study on mechanism for amorphous drug stabilization using gelucire 50/13. | Chemical & pharmaceutical bulletin 20090901 |
| Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimidinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitors. | Bioorganic & medicinal chemistry letters 20090801 |
| Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis. | Drugs 20090730 |
| The effect of etoricoxib on the pharmacokinetics of oral contraceptives in healthy participants. | Journal of clinical pharmacology 20090701 |
| Serum urate during acute gout. | The Journal of rheumatology 20090601 |
| Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program. | European journal of heart failure 20090601 |
| Computer simulations using GastroPlus to justify a biowaiver for etoricoxib solid oral drug products. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20090501 |
| Synthesis of hyaluronan in oesophageal cancer cells is uncoupled from the prostaglandin-cAMP pathway. | British journal of pharmacology 20090501 |
| Single dose oral etoricoxib for acute postoperative pain in adults. | The Cochrane database of systematic reviews 20090415 |
| Pain control in first trimester surgical abortion. | The Cochrane database of systematic reviews 20090415 |
| Determination of two COX-2 inhibitors in serum and synovial fluid of patients with inflammatory arthritis by ultra performance liquid chromatography-inductively coupled plasma mass spectroscopy and quadrupole time-of-flight mass spectrometry. | Journal of pharmaceutical and biomedical analysis 20090405 |
| Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study). | Rheumatology (Oxford, England) 20090401 |
| Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study. | Journal of hypertension 20090401 |
| Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients. | Annals of the rheumatic diseases 20090301 |
| Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation. | Cardiovascular research 20090201 |
| How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial. | The American journal of gastroenterology 20090201 |
| Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib. | European journal of clinical pharmacology 20090101 |
| Effect of PVP K30 and/or L-arginine on stability constant of etoricoxib-HPbetaCD inclusion complex: preparation and characterization of etoricoxib-HPbetaCD binary system. | Drug development and industrial pharmacy 20090101 |
| Frequency of ill-founded off-label prescribing in Dutch general practice. | Pharmacoepidemiology and drug safety 20090101 |
| Complexation of cox-2 inhibitors with bovine serum albumin: interaction mechanism. | Pharmaceutical development and technology 20090101 |
| Management of rheumatoid arthritis: summary of NICE guidance. | BMJ (Clinical research ed.) 20090101 |
| Competition between COX-2 inhibitors and some other drugs for binding sites on human serum albumin. | Drug metabolism and drug interactions 20090101 |
| The cyclooxygenase-2 inhibitor etoricoxib is a potent chemopreventive agent of colon carcinogenesis in the rat model. | Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 20090101 |
| The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study. | Journal of orthopaedic surgery and research 20090101 |
| Cardiovascular and hematologic effects produced by chronic treatment with etoricoxib in normotensive rats. | Acta cirurgica brasileira 20090101 |
| Physicochemical investigation of the solid dispersion systems of etoricoxib with poloxamer 188. | Pharmaceutical development and technology 20090101 |
| Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis. | BMJ (Clinical research ed.) 20090101 |
| Gout. Novel therapies for treatment of gout and hyperuricemia. | Arthritis research & therapy 20090101 |
| Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis. | Arthritis research & therapy 20090101 |
| Effect of non-steroidal anti-inflammatory drug etoricoxib on the hematological parameters and enzymes of colon and kidney. | Nutricion hospitalaria 20090101 |
| Drugs associated with more suicidal ideations are also associated with more suicide attempts. | PloS one 20090101 |
| Chemopreventive effect of nonsteroidal anti-inflammatory drugs on 9,10-dimethylbenz[a]anthracene-induced lung carcinogenesis in mice. | Oncology research 20090101 |
| Low-dose aspirin reduces gastro-protective properties of COX-2 selective inhibitors. | Clinical drug investigation 20090101 |
| Celecoxib in arthritis: relative risk management profile and implications for patients. | Therapeutics and clinical risk management 20090101 |
| [Comparison of the analgesic effect between 90 mg etoricoxib and dipyrone after exeresis of primary pterygium with conjunctival autograft]. | Arquivos brasileiros de oftalmologia 20090101 |
| Long-term tolerability of etoricoxib in patients with previous reactions to non-steroidal anti-inflammatory drugs. | International journal of immunopathology and pharmacology 20090101 |
| Long-Term Alendronate Use Not without Consequences? | International journal of rheumatology 20090101 |
| Chemoprevention of 1,2-dimethylhydrazine-induced colon carcinogenesis by a non-steroidal anti-inflammatory drug, etoricoxib, in rats: inhibition of nuclear factor kappaB. | Asian Pacific journal of cancer prevention : APJCP 20090101 |
| Na(+)-stimulated Na+/H+ exchange and an unfavorable Ca2+ homeostasis initiate the cycloxygenase-2 inhibitors-induced apoptotic signals in colonic epithelial cells during the early stage of colon carcinogenesis. | Oncology research 20090101 |
| Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. | Drug, healthcare and patient safety 20090101 |
| [Overdose of etoricoxib: 840mg]. | Reumatologia clinica 20090101 |
| [Primary hypertrophic osteoarthropathy (pachydermoperiostosis). Report of two familial cases and literature review]. | Reumatologia clinica 20090101 |
| Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib. | British journal of clinical pharmacology 20081201 |
| Antiinflammatory effects of etoricoxib alone and combined with NSAIDs in LPS-induced reactive arthritis. | Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20081201 |
| Systems biology: a therapeutic target for tumor therapy. | Cancer microenvironment : official journal of the International Cancer Microenvironment Society 20081201 |
| Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis. | Osteoarthritis and cartilage 20081101 |
| Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. | Gastroenterology 20081101 |
| Celecoxib inhibits 5-lipoxygenase. | Biochemical pharmacology 20081001 |
| Experimentally induced various inflammatory models and seizure: understanding the role of cytokine in rat. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20081001 |
| Comparison of etoricoxib vs. ketorolac in postoperative pain relief. | Acta anaesthesiologica Scandinavica 20081001 |
| Risk management profile of etoricoxib: an example of personalized medicine. | Therapeutics and clinical risk management 20081001 |
| Neuropharmacology. | Indian journal of pharmacology 20081001 |
| Clinical pharmacology. | Indian journal of pharmacology 20081001 |
| Prospective randomized, double-blinded, placebo-controlled trial of preoperative etoricoxib for pain relief in uterine fractional curettage under paracervical block. | European journal of obstetrics, gynecology, and reproductive biology 20080901 |
| Adjunctive benefits of systemic etoricoxib in non-surgical treatment of aggressive periodontitis: short-term evaluation. | Journal of periodontology 20080901 |
| Thermodynamic behavior of glassy state of structurally related compounds. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080801 |
| Can drug removals involving cyclooxygenase-2 inhibitors be avoided? A plea for human pharmacology. | Trends in pharmacological sciences 20080801 |
| Asthmatic reaction induced by Etoricoxib in a patient with aspirin-sensitive asthma. | Allergy 20080801 |
| In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions. | Basic & clinical pharmacology & toxicology 20080801 |
| The anti-proliferative potency of celecoxib is not a class effect of coxibs. | Biochemical pharmacology 20080715 |
| The effect of etoricoxib premedication on postoperative analgesia requirement in orthopedic and trauma patients. | Saudi medical journal 20080701 |
| Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects. | Journal of clinical pharmacology 20080601 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20080601 |
| Cardiovascular co-morbidity in rheumatic diseases. | Vascular health and risk management 20080601 |
| Etoricoxib and intermittent androgen deprivation therapy in patients with biochemical progression after radical prostatectomy. | Urology 20080501 |
| The efficacy of etoricoxib vs mefenamic acid in the treatment of primary dysmenorrhoea: a randomised comparative trial. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20080501 |
| Trypanosoma cruzi: the role of PGE2 in immune response during the acute phase of experimental infection. | Experimental parasitology 20080401 |
| Safe adalimumab therapy for rheumatoid arthritis in a patient with pre-existing multiple myeloma. | Nature clinical practice. Rheumatology 20080401 |
| Evaluation of the changes in hemostatic parameters induced by etoricoxib in rat model. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20080401 |
| Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. | Health technology assessment (Winchester, England) 20080401 |
| Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis. | Therapeutics and clinical risk management 20080401 |
| Etoricoxib, paracetamol, and dextropropoxyphene for postoperative pain management: a questionnaire survey of consumption of take-home medication after elective hallux valgus surgery. | Foot & ankle specialist 20080401 |
| Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II). | Annals of the rheumatic diseases 20080301 |
| Clinical use and pharmacological properties of selective COX-2 inhibitors. | European journal of clinical pharmacology 20080301 |
| Correlation of measures of pain, function, and overall response: results pooled from two identical studies of etoricoxib in chronic low back pain. | Spine 20080301 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20080301 |
| Upregulation of ICAM-1 expression in bronchial epithelial cells by airway secretions in bronchiectasis. | Respiratory medicine 20080201 |
| Preclinical pharmacology profile of CS-706, a novel cyclooxygenase-2 selective inhibitor, with potent antinociceptive and anti-inflammatory effects. | European journal of pharmacology 20080106 |
| Cyclooxygenase-2 expression on ifosfamide-induced hemorrhagic cystitis in rats. | Journal of cancer research and clinical oncology 20080101 |
| Effects of nonsteroidal anti-inflammatory drugs on the expression of urokinase plasminogen activator and inhibitor and gelatinases in the early osteoarthritic knee of humans. | Clinical biochemistry 20080101 |
| Validation of a capillary zone electrophoresis method for the comparative determination of etoricoxib in pharmaceutical formulations. | Journal of separation science 20080101 |
| Etoricoxib for pain management during thyroid surgery--a prospective, placebo-controlled study. | Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20080101 |
| Primary stabbing headache can be responsive to etoricoxib, a selective COX-2 inhibitor. | European journal of neurology 20080101 |
| Etoricoxib-induced erythema-multiforme-like eruption. | Dermatology (Basel, Switzerland) 20080101 |
| Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes. | Arthritis research & therapy 20080101 |
| Etoricoxib-induced acute generalized exanthematous pustulosis. | Acta dermato-venereologica 20080101 |
| Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: a randomised controlled trial in patients with osteoarthritis. | BMC musculoskeletal disorders 20080101 |
| Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores. | Arthritis research & therapy 20080101 |
| Efficacy of etoricoxib for pain relief during endometrial biopsy; a double blind randomized controlled trial. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080101 |
| Prevention of post operative pain after abdominal hysterectomy by single dose etoricoxib. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080101 |
| The cardiovascular risks of etoricoxib (Arcoxia). | Annals of Saudi medicine 20080101 |
| Effect of nonsteroidal anti-inflammatory drugs and the procarcinogen 1,2-dimethylhydrazine on the antioxidant defense system. | International journal of toxicology 20080101 |
| Effects of etoricoxib on the pharmacokinetics of phenytoin. | Pharmacological reports : PR 20080101 |
| Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports. | Arthritis research & therapy 20080101 |
| Use and misuse of the p-value. | Bulletin of the NYU hospital for joint diseases 20080101 |
| Superiority, equivalence, and non-inferiority trials. | Bulletin of the NYU hospital for joint diseases 20080101 |
| Antioxidative effects of nonsteroidal anti-inflammatory drugs during the initiation stages of experimental colon carcinogenesis in rats. | Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 20080101 |
| Safety of etoricoxib in patients with reactions to NSAIDs. | Journal of investigational allergology & clinical immunology 20080101 |
| Design, development, and optimization of orally disintegrating tablets of etoricoxib using vacuum-drying approach. | PDA journal of pharmaceutical science and technology 20080101 |
| A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. | Arthritis research & therapy 20080101 |
| A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients. | BMC musculoskeletal disorders 20080101 |
| Sevoflurane requirement during elective ankle day surgery: the effects of etirocoxib premedication, a prospective randomised study. | Journal of orthopaedic surgery and research 20080101 |
| Life satisfaction in patients with long-term non-malignant pain - relating LiSat-11 to the Multidimensional Pain Inventory (MPI). | Health and quality of life outcomes 20080101 |
| Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study. | Clinical drug investigation 20080101 |
| Clinical pharmacokinetic and pharmacodynamic profile of etoricoxib. | Clinical pharmacokinetics 20080101 |
| New horizons and perspectives in the treatment of osteoarthritis. | Arthritis research & therapy 20080101 |
| Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis. | Arthritis research & therapy 20080101 |
| A rare cause of a common symptom, Anakinra is effective in the urticaria of Schnitzler Syndrome: a case report. | Cases journal 20080101 |
| Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system. | BMC musculoskeletal disorders 20080101 |
| Cyclooxygenase-2 inhibition by etoricoxib modulates plasma membrane fluidity in rat colon. | Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 20080101 |
| Selective immediate hypersensitivity to etoricoxib. | Journal of investigational allergology & clinical immunology 20080101 |
| [Cardiovascular risk of cyclooxygenase selective inhibitors]. | Revista medica del Instituto Mexicano del Seguro Social 20080101 |
| Effect of non-steroidal anti-inflammatory drugs and the pro-carcinogen 1,2 dimethylhydrazine on the rat intestinal membrane structure and function. | Nutricion hospitalaria 20080101 |
| Influence of COX-2-induced PGE2 on the initiation and progression of tail regeneration in Northern House Gecko, Hemidactylus flaviviridis. | Folia biologica 20080101 |
| FTIR studies on differential intermolecular association in crystalline and amorphous states of structurally related non-steroidal anti-inflammatory drugs. | Molecular pharmaceutics 20080101 |
| The effect of etoricoxib, a cyclooxygenase-2-specific inhibitor, on the 1,2-dimethylhydrazine-administered rat intestinal membrane structure and function. | Toxicology mechanisms and methods 20080101 |
| Preparation and evaluation of transdermal drug delivery system of etoricoxib using modified chitosan. | Indian journal of pharmaceutical sciences 20080101 |
| Optimization of fast dissolving etoricoxib tablets prepared by sublimation technique. | Indian journal of pharmaceutical sciences 20080101 |
| Aspirin-exacerbated asthma. | Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20080101 |
| Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors. | Bioorganic & medicinal chemistry letters 20071215 |
| A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis. | Osteoarthritis and cartilage 20071201 |
| Assessment of outcome in clinical trials of gout--a review of current measures. | Rheumatology (Oxford, England) 20071201 |
| Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet. | Journal of clinical pharmacology 20071201 |
| Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of ankylosing spondylitis in the UK. | Current medical research and opinion 20071201 |
| Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain. | Prescrire international 20071201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20071201 |
| [What is new about nonsteroidal antiinflamatory drugs?]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20071201 |
| Update on the treatment of ankylosing spondylitis. | Therapeutics and clinical risk management 20071201 |
| Etoricoxib challenge in patients with chronic urticaria with NSAID intolerance. | Clinical and experimental dermatology 20071101 |
| Analgesic effect of etoricoxib in secondary dysmenorrhea: a randomized, double-blind, crossover, controlled trial. | The Journal of reproductive medicine 20071101 |
| Covalent binding of rofecoxib, but not other cyclooxygenase-2 inhibitors, to allysine aldehyde in elastin of human aorta. | Drug metabolism and disposition: the biological fate of chemicals 20071001 |
| Lack of effect of antacids on single-dose pharmacokinetics of etoricoxib. | Journal of clinical pharmacology 20071001 |
| COX-2 inhibitor. | Rheumatology (Oxford, England) 20071001 |
| Application of polyglycolized glycerides in protection of amorphous form of etoricoxib during compression. | Chemical & pharmaceutical bulletin 20071001 |
| Selective COX-2 inhibitors, NSAIDs and cardiovascular events - is celecoxib the safest choice? | Therapeutics and clinical risk management 20071001 |
| Etoricoxib versus naproxen in patients with rheumatoid arthritis: a prospective, randomized, comparator-controlled 121-week trial. | Current medical research and opinion 20070901 |
| Preparation and characterization of etoricoxib-beta-cyclodextrin complexes prepared by the kneading method. | Acta pharmaceutica (Zagreb, Croatia) 20070901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20070901 |
| Rosiglitazone: a disappointing DREAM. | Future cardiology 20070901 |
| Keeping science on top in drug evaluation. | The New England journal of medicine 20070816 |
| Anti-inflammatory and analgesic actions of etoricoxib (an NSAID) combined with misoprostol. | Inflammopharmacology 20070801 |
| Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis. | Annals of the rheumatic diseases 20070701 |
| Risk of myocardial infarction associated with selective COX-2 inhibitors: meta-analysis of randomised controlled trials. | Pharmacoepidemiology and drug safety 20070701 |
| Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature. | Archives of dermatological research 20070701 |
| Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20070701 |
| COX-2 in play at the AHA and the FDA. | Trends in pharmacological sciences 20070701 |
| Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout. | Current medical research and opinion 20070701 |
| Oral etoricoxib for pain relief during fractional curettage: a randomized controlled trial. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20070601 |
| Few options available for arthritis pain relief. FDA declines to approve Merck's Arcoxia. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070515 |
| Is administration time of oral non-steroid anti-inflammatory drugs important? A clinical study in patients undergoing arthroscopic subacromial decompression. | European journal of anaesthesiology 20070501 |
| The effect of etoricoxib on the pharmacodynamics and pharmacokinetics of warfarin. | Journal of clinical pharmacology 20070501 |
| Effects of COX-2 inhibitor in temporomandibular joint acute inflammation. | Journal of dental research 20070501 |
| A study on the effects of diclofenac sodium and etoricoxib in the treatment of osteoarthritis. | Journal of the Indian Medical Association 20070501 |
| Gastrointestinal safety of NSAIDs versus COX-2 inhibitors. | Lancet (London, England) 20070421 |
| [Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain]. | Nederlands tijdschrift voor geneeskunde 20070407 |
| [By what means does the rheumatic patient with gastrointestinal risks fare best?]. | MMW Fortschritte der Medizin 20070308 |
| Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. | Rheumatology (Oxford, England) 20070301 |
| Etoricoxib pre-medication combined with intra-operative subacromial block for pain after arthroscopic acromioplasty. | Acta anaesthesiologica Scandinavica 20070301 |
| Therapeutic advances in gout. | Current opinion in rheumatology 20070301 |
| Dynamic simulations on the arachidonic acid metabolic network. | PLoS computational biology 20070301 |
| Cardiovascular safety of cyclo-oxygenase-2 inhibitors. | Lancet (London, England) 20070217 |
| Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. | Lancet (London, England) 20070210 |
| Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial. | The Journal of rheumatology 20070201 |
| Tolerance to etoricoxib in 37 patients with urticaria and angioedema induced by nonsteroidal anti-inflammatory drugs. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20070201 |
| NSAID trials and the choice of comparators--questions of public health importance. | The New England journal of medicine 20070125 |
| Pharmacodynamic of cyclooxygenase inhibitors in humans. | Prostaglandins & other lipid mediators 20070101 |
| Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20070101 |
| Etoricoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs. | International archives of allergy and immunology 20070101 |
| Stroke caused by small vessel occlusion in a patient taking etoricoxib and thalidomide. | Journal of neuroimaging : official journal of the American Society of Neuroimaging 20070101 |
| Evaluation of the patient acceptable symptom state in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis. | Arthritis research & therapy 20070101 |
| Etoricoxib was noninferior to diclofenac for cardiovascular outcomes in osteoarthritis and rheumatoid arthritis. | ACP journal club 20070101 |
| Emerging from the shadow of Vioxx. | Current topics in medicinal chemistry 20070101 |
| Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study. | Arthritis research & therapy 20070101 |
| An economic model of long-term use of celecoxib in patients with osteoarthritis. | BMC gastroenterology 20070101 |
| Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. | BMC clinical pharmacology 20070101 |
| Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk. | BMC musculoskeletal disorders 20070101 |
| Efficacy of the newest COX-2 selective inhibitors in rheumatic disease. | Current pharmaceutical design 20070101 |
| Global gastrointestinal safety profile of etoricoxib and lumiracoxib. | Current pharmaceutical design 20070101 |
| Molecular and thermodynamic aspects of solubility advantage from solid dispersions. | Molecular pharmaceutics 20070101 |
| The use of etoricoxib to treat an idiopathic stabbing headache: a case report. | Journal of medical case reports 20070101 |
| Chemopreventive effects of nonsteroidal anti-inflammatory drugs in the membrane lipid composition and fluidity parameters of the 1,2-dimethylhydrazine-induced colon carcinogenesis in rats. | Drug and chemical toxicology 20070101 |
| Multi-modal-analgesia for pain management after Hallux Valgus surgery: a prospective randomised study on the effect of ankle block. | Journal of orthopaedic surgery and research 20070101 |
| Clinical management of adult patients with a history of nonsteroidal anti-inflammatory drug-induced urticaria/angioedema: update. | Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20070101 |
| Role of early minimal-invasive spine fixation in acute thoracic and lumbar spine trauma. | Indian journal of orthopaedics 20070101 |
| Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis. | Core evidence 20070101 |
| Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile. | Pharmacoepidemiology and drug safety 20061201 |
| Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials. | Journal of clinical pharmacy and therapeutics 20061201 |
| Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX-2 selective Inhibitor etoricoxib. | Current medical research and opinion 20061201 |
| [Coronary risks with NSAID and coxibs. The end of hysteria]. | MMW Fortschritte der Medizin 20061130 |
| [3 questions about gastrointestinal risk. Are coxibs here clearly better than NSAID?]]. | MMW Fortschritte der Medizin 20061130 |
| The ever growing story of cyclo-oxygenase inhibition. | Lancet (London, England) 20061118 |
| Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. | Lancet (London, England) 20061118 |
| Effectiveness of interventions for the treatment of acute and prevention of recurrent gout--a systematic review. | Rheumatology (Oxford, England) 20061101 |
| In-line measurement of a drug substance via near infrared spectroscopy to ensure a robust crystallization process. | Journal of pharmaceutical sciences 20061101 |
| Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT). | PLoS clinical trials 20061101 |
| Nonsteroidal anti-inflammatory drugs: cyclooxygenase 2 inhibitors. | Jornal de pediatria 20061101 |
| Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials. | JAMA 20061004 |
| Selective COX-2 inhibitors and risk of thromboembolic events - regulatory aspects. | Thrombosis and haemostasis 20061001 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20061001 |
| Preparation and characterization of etoricoxib-polyethylene glycol 4000 plus polyvinylpyrrolidone K30 solid dispersions. | Acta pharmaceutica (Zagreb, Croatia) 20060901 |
| An animal model of chronic inflammatory pain: pharmacological and temporal differentiation from acute models. | European journal of pain (London, England) 20060801 |
| Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis. | American heart journal 20060801 |
| Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study. | Stroke 20060701 |
| Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060701 |
| Etoricoxib pre-medication for post-operative pain after laparoscopic cholecystectomy. | Acta anaesthesiologica Scandinavica 20060701 |
| Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx and Arcoxia. | Bioorganic & medicinal chemistry letters 20060615 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20060601 |
| Treating axial manifestations in ankylosing spondylitis in the presence of peripheral arthritis. | Nature clinical practice. Rheumatology 20060601 |
| Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. | Blood 20060501 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20060501 |
| Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. | Circulation 20060425 |
| Different COX-independent effects of the COX-2 inhibitors etoricoxib and lumiracoxib. | Biochemical and biophysical research communications 20060414 |
| Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy. | Blood 20060301 |
| Editorial foreword. | Therapeutics and clinical risk management 20060301 |
| Etoricoxib for arthritis and pain management. | Therapeutics and clinical risk management 20060301 |
| Analysis of interaction between etoricoxib and tramadol against mechanical hyperalgesia of spinal cord injury in rats. | Life sciences 20060209 |
| The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases. | The American journal of gastroenterology 20060201 |
| Simultaneous quantitation of etoricoxib, salicylic acid, valdecoxib, ketoprofen, nimesulide and celecoxib in plasma by high-performance liquid chromatography with UV detection. | Biomedical chromatography : BMC 20060101 |
| Investigating the hydrate conversion propensity of different etoricoxib lots. | Journal of pharmaceutical sciences 20060101 |
| Multiple drug intolerance including etoricoxib. | Allergy 20060101 |
| Systematic review: coxibs, non-steroidal anti-inflammatory drugs or no cyclooxygenase inhibitors in gastroenterological high-risk patients? | Alimentary pharmacology & therapeutics 20060101 |
| The use of etoricoxib in patients with bronchial asthma associated with aspirin sensitivity. | Saudi medical journal 20060101 |
| [Brief coxib therapy lowers cardiovascular risk]. | Zeitschrift fur Orthopadie und ihre Grenzgebiete 20060101 |
| The inflammatory process of gout and its treatment. | Arthritis research & therapy 20060101 |
| Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England. | Drug safety 20060101 |
| Fixed drug eruption and generalised erythema following etoricoxib. | Indian journal of dermatology, venereology and leprology 20060101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20060101 |
| Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. | Arthritis research & therapy 20060101 |
| Validation of liquid chromatography and liquid chromatography/tandem mass spectrometry methods for the determination of etoricoxib in pharmaceutical formulations. | Journal of AOAC International 20060101 |
| Interaction of non-steroidal anti-inflammatory drugs, etoricoxib and parecoxib sodium, with human serum albumin studied by fluorescence spectroscopy. | Drug metabolism and drug interactions 20060101 |
| Meloxicam tolerance in hypersensitivity to nonsteroidal anti-inflammatory drugs. | Journal of investigational allergology & clinical immunology 20060101 |
| Adverse cutaneous reactions to selective cyclooxygenase 2 inhibitors: experience of an Italian drug-surveillance center. | Journal of cutaneous medicine and surgery 20060101 |
| C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation. | Biomarker insights 20060101 |
| Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study. | Current medical research and opinion 20051201 |
| Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis. | Annals of the rheumatic diseases 20051101 |
| Impact of CYP2C9 genotype on pharmacokinetics: are all cyclooxygenase inhibitors the same? | Drug metabolism and disposition: the biological fate of chemicals 20051101 |
| Short-term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20051101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20051101 |
| Systematic review and meta-analysis of the risk of major cardiovascular events with etoricoxib therapy. | The New Zealand medical journal 20051007 |
| A general method for the synthesis of aryl [11C]methylsulfones: potential PET probes for imaging cyclooxygenase-2 expression. | Bioorganic & medicinal chemistry letters 20051001 |
| Stabilization and improved in vivo performance of amorphous etoricoxib using Gelucire 50/13. | Pharmaceutical research 20051001 |
| Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery: a randomized, double-blind, placebo-controlled study. | Anesthesia and analgesia 20051001 |
| An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices. | Journal of pharmaceutical and biomedical analysis 20050915 |
| Adverse effects of etoricoxib: other considerations. | Mayo Clinic proceedings 20050901 |
| Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique. | AAPS PharmSciTech 20050901 |
| Need for common internal controls when assessing the relative efficacy of pharmacologic agents using a meta-analytic approach: case study of cyclooxygenase 2-selective inhibitors for the treatment of osteoarthritis. | Arthritis and rheumatism 20050815 |
| [The efficacy of selective Cox-2-inhibitors in comparison with conventional NSAIDs]. | MMW Fortschritte der Medizin 20050804 |
| The molecular basis for coxib inhibition of p38alpha MAP kinase. | Bioorganic & medicinal chemistry letters 20050801 |
| Analgesic efficacy of pre-operative etoricoxib for termination of pregnancy in an ambulatory centre. | Singapore medical journal 20050801 |
| Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray? | Current medical research and opinion 20050801 |
| Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20050801 |
| Clinical pharmacology of etoricoxib. | Expert opinion on drug metabolism & toxicology 20050801 |
| 3-[4-(methylsulfonyl)phenyl]-5-(trifluoromethyl)(2-pyridyl) phenyl ketone as a potent and orally active cyclooxygenase-2 selective inhibitor: synthesis and biological evaluation. | Journal of medicinal chemistry 20050602 |
| Protective effects of etoricoxib, a selective inhibitor of cyclooxygenase-2, in experimental periodontitis in rats. | Journal of periodontal research 20050601 |
| Etoricoxib: a highly selective COX-2 inhibitor. | The Annals of pharmacotherapy 20050501 |
| Association between health-related quality of life and clinical efficacy endpoints in rheumatoid arthritis patients after four weeks treatment with anti-inflammatory agents. | International journal of clinical pharmacology and therapeutics 20050501 |
| The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis. | Current medical research and opinion 20050501 |
| Quantitation of itopride in human serum by high-performance liquid chromatography with fluorescence detection and its application to a bioequivalence study. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050425 |
| [COX-2 inhibitors--one step forward and two steps back]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20050407 |
| Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study. | Arthritis and rheumatism 20050401 |
| Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial. | Mayo Clinic proceedings 20050401 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050401 |
| A liquid chromatography-mass spectrometry method for the quantification of both etoricoxib and valdecoxib in human plasma. | Biomedical chromatography : BMC 20050301 |
| Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity. | The Journal of pharmacology and experimental therapeutics 20050301 |
| Coxibs: can this class of drugs survive? | Vascular health and risk management 20050301 |
| Validated liquid chromatographic ultraviolet method for the quantitation of Etoricoxib in human plasma using liquid-liquid extraction. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050225 |
| Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins. | Circulation research 20050107 |
| Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly? | Drugs & aging 20050101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050101 |
| The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction pain. | Current medical research and opinion 20050101 |
| Relative thromboembolic risks associated with COX-2 inhibitors. | The Annals of pharmacotherapy 20050101 |
| COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective. | Current topics in medicinal chemistry 20050101 |
| Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK. | PharmacoEconomics 20050101 |
| Current state of therapy for pain and inflammation. | Arthritis research & therapy 20050101 |
| Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance. | Arthritis research & therapy 20050101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050101 |
| Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]. | BMC musculoskeletal disorders 20050101 |
| Comparative efficacy of aceclofenac and etoricoxib in post extraction pain control: randomized control trial. | Indian journal of dental research : official publication of Indian Society for Dental Research 20050101 |
| Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs. | Atherosclerosis 20041201 |
| Novel insights and therapeutical applications in the field of inhibitors of COX-2. | Current medicinal chemistry 20041201 |
| Isolation and structural characterization of the photolysis products of etoricoxib. | Die Pharmazie 20041201 |
| [Comparison of preemptive analgesia efficacy between etoricoxib and rofecoxib in ambulatory gynecological surgery]. | Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20041201 |
| Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs. | Current medical research and opinion 20041201 |
| Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitors. | Bioorganic & medicinal chemistry letters 20041101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20041101 |
| The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activity. | Journal of clinical pharmacology 20041001 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20041001 |
| The analgesic efficacy of etoricoxib compared with oxycodone/acetaminophen in an acute postoperative pain model: a randomized, double-blind clinical trial. | Anesthesia and analgesia 20040901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20040901 |
| First and second generations of COX-2 selective inhibitors. | Mini reviews in medicinal chemistry 20040801 |
| The second generation of COX-2 inhibitors: clinical pharmacological point of view. | Mini reviews in medicinal chemistry 20040801 |
| Synthesis and biological evaluation of 2-phenylpyran-4-ones: a new class of orally active cyclooxygenase-2 inhibitors. | Journal of medicinal chemistry 20040715 |
| Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations. | Alimentary pharmacology & therapeutics 20040701 |
| Prostaglandins: modulators of inflammation and cardiovascular risk. | Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20040601 |
| Management strategies for osteoarthritis, ankylosing spondylitis, and gouty arthritis. | Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20040601 |
| Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20040501 |
| Evaluation of quality of life following treatment with etoricoxib in patients with arthritis or low-back pain: an open label, uncontrolled pilot study in Mexico. | Current medical research and opinion 20040501 |
| Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study. | Clinical therapeutics 20040501 |
| [Etoricoxib (Arcoxia)]. | Revue medicale de Liege 20040501 |
| Etoricoxib. | Drugs of today (Barcelona, Spain : 1998) 20040501 |
| [Pharmacology and classification of cyclooxygenase inhibitors]. | Gastroenterologie clinique et biologique 20040401 |
| In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxygenase-2 inhibitors: 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives. | Journal of medicinal chemistry 20040212 |
| Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial. | Arthritis and rheumatism 20040201 |
| Cyclooxygenase-2 inhibitors: do they have a role in emergency department prescribing? | Emergency medicine Australasia : EMA 20040201 |
| Pharmacological characterisation of a rat model of incisional pain. | British journal of pharmacology 20040101 |
| Pharmacokinetics of etoricoxib in patients with renal impairment. | Journal of clinical pharmacology 20040101 |
| Clinical pharmacology of novel selective COX-2 inhibitors. | Current pharmaceutical design 20040101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20040101 |
| Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials. | Clinical therapeutics 20040101 |
| A randomized, double-blind, parallel-group study comparing the analgesic effect of etoricoxib to placebo, naproxen sodium, and acetaminophen with codeine using the dental impaction pain model. | The Clinical journal of pain 20040101 |
| Selective cyclooxygenase-2 inhibitors: similarities and differences. | Scandinavian journal of rheumatology 20040101 |
| A mechanistic perspective on the specificity and extent of COX-2 inhibition in pregnancy. | Drug safety 20040101 |
| Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK. | PharmacoEconomics 20040101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20040101 |
| Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. | Scandinavian journal of rheumatology 20040101 |
| [Rapidly acting and powerful antirheumatic drug now also approved in Germany. Arcoxia (etoricoxib, MSD)]]. | Krankenpflege Journal 20040101 |
| The role of cyclooxygenase selective inhibitors in the gastrointestinal tract. | Current gastroenterology reports 20031201 |
| Pharmacokinetics of etoricoxib in patients with hepatic impairment. | Journal of clinical pharmacology 20031001 |
| The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. | The American journal of gastroenterology 20030801 |
| Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial. | The journal of pain : official journal of the American Pain Society 20030801 |
| Characterization of etoricoxib, a novel, selective COX-2 inhibitor. | Journal of clinical pharmacology 20030601 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20030601 |
| A literature review of the epidemiology and treatment of acute gout. | Clinical therapeutics 20030601 |
| Determination of etoricoxib in human plasma by liquid chromatography-tandem mass spectrometry with electrospray ionisation. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030525 |
| Etoricoxib in the treatment of chronic pain. | International journal of clinical practice 20030501 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20030501 |
| [Coxibs: highly selective cyclooxygenase-2 inhibitors. Part II. Side effects]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20030401 |
| Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man. | Journal of clinical pharmacology 20030301 |
| Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteers. | Drug metabolism and disposition: the biological fate of chemicals 20030201 |
| Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitor. | Expert opinion on pharmacotherapy 20030201 |
| The second generation of COX-2 inhibitors: what advantages do the newest offer? | Drugs 20030101 |
| Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib. | Alimentary pharmacology & therapeutics 20030101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20030101 |
| Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors. | Arthritis research & therapy 20030101 |
| COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients. | Arthritis research & therapy 20030101 |
| COX-2: where are we in 2003?--distinction from NSAIDs becoming blurred. | Arthritis research & therapy 20030101 |
| Analgesic efficacy of etoricoxib in primary dysmenorrhea: results of a randomized, controlled trial. | Gynecologic and obstetric investigation 20030101 |
| Meloxicam and selective COX-2 inhibitors in the management of pain in the palliative care population. | The American journal of hospice & palliative care 20030101 |
| Clinical pharmacology of selective COX-2 inhibitors. | International journal of immunopathology and pharmacology 20030101 |
| A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis. | Current medical research and opinion 20030101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20021201 |
| Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis. | Rheumatology (Oxford, England) 20020901 |
| COX-2 inhibition and the control of pain. | Current opinion in investigational drugs (London, England : 2000) 20020901 |
| Another selective COX-2 inhibitor: more questions than answers? | The Journal of rheumatology 20020801 |
| A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis. | The Journal of rheumatology 20020801 |
| Role of COX-2 inhibitors in the evolution of acute pain management. | Journal of pain and symptom management 20020701 |
| Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. | BMJ (Clinical research ed.) 20020622 |
| Gateways to Clinical Trials. June 2002. | Methods and findings in experimental and clinical pharmacology 20020601 |
| Cox-2 inhibitors: today and tomorrow. | The American journal of the medical sciences 20020401 |
| Simultaneous determination of unlabeled and carbon-13-labeled etoricoxib, a new cyclooxygenase-2 inhibitor, in human plasma using HPLC-MS/MS. | Journal of pharmaceutical sciences 20020201 |
| Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial. | Current medical research and opinion 20020101 |
| A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]. | BMC family practice 20020101 |
| COX-2-selective inhibitors in the treatment of arthritis. | Cleveland Clinic journal of medicine 20020101 |
| Development and clinical application of COX-2-selective inhibitors for the treatment of osteoarthritis and rheumatoid arthritis. | Cleveland Clinic journal of medicine 20020101 |
| Etoricoxib. | Drugs 20020101 |
| The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity. | Current medical research and opinion 20020101 |
| Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers. | Journal of clinical pharmacology 20011001 |
| Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitor. | Drug metabolism and disposition: the biological fate of chemicals 20010601 |
| In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663). | Bioorganic & medicinal chemistry letters 20010423 |
| Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. | The Journal of pharmacology and experimental therapeutics 20010201 |
| Investigational COX-2 inhibitor relieves pain in dental model. | Current pain and headache reports 20010201 |
| Preparation and novel reduction reactions of vinamidinium salts. | The Journal of organic chemistry 20010112 |